Funding for this research was provided by:
National Cancer Institute (UM1 CA182910, CA77305, R01CA184545, R37 CA54281, R01CA120120, CA142996, 5UM1CA164973, CA63446, R01 CA132839, UM1 CA164920, CA161032, R01 CA63464, R25CA112355, R01CA148667, K24CA169004)
U.S. Department of Defense (DAMD17-96-1-6071)
California Breast Cancer Research Program (7PB-0068)
Consejo Nacional de Ciencia y Tecnología (SALUD-2002-C01-7462)
V Foundation for Cancer Research
American Cancer Society (MRSG-13-063-01-TBG and CRP-10-119-01-CCE)
Susan G. Komen for the Cure
Breast Cancer Research Foundation
Received: 9 April 2018
Accepted: 4 December 2018
First Online: 14 January 2019
Ethics approval and consent to participate
: The following Institutional Review Boards (IRBs) have approved the collection of different datasets, which have contributed to this study: University of California, San Francisco, the Cancer Prevention Institute of California, University of Southern California, Kaiser Permanente Division of Research Northern California, University of Chicago, Vanderbilt University, National Institute of Public Health, Mexico.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.